首页 › 基金 › Stonepine Capital Management, LLC › XFOR

Stonepine Capital Management, LLC 对 XFOR 的持仓历史

X4 PHARMACEUTICALS INC · 医疗保健

Stonepine Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 XFOR(X4 PHARMACEUTICALS INC)224,989 股,市值约 US$1.1M,约占其申报组合的 0.69%,在其申报持仓中市值排名第 35 位。 Stonepine Capital Management, LLC 最近 12 个申报季度中有 5 个季度披露了 XFOR 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)224.99K 股
申报持仓市值$1.05M
组合权重0.69%
首次申报Q3 2023
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Stonepine Capital Management, LLC 对 XFOR 的持仓演变

Stonepine Capital Management, LLC 于 Q3 2023 首次披露 XFOR 持仓:5,273,685 股(约 US$5.7M)。 在 5 次申报中,Stonepine Capital Management, LLC 0 次增持、3 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 224,989 股、市值约 US$1.1M,环比减持 -110,320 股。。 持仓曾出现大幅变动:Q4 2025 减持约 44% (随后一个季度股价上涨 3%)、Q1 2026 减持约 44% (随后一个季度股价上涨 13%)、Q2 2026 减持约 33% (随后一个季度股价下跌 38%)。

逐季持仓明细

季度股数金额变化
Q3 2023 5.27M $5.75M 新进
Q3 2025 1.06M $3.61M 新进
Q4 2025 593.57K $2.37M 减持
Q1 2026 335.31K $1.38M 减持
Q2 2026 224.99K $1.05M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 XFOR 与 13F 数据

XFOR(X4 PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 XFOR,申报仓位最大的包括:Bain Capital Life Sciences Investors, LLC (US$37.2M), PERCEPTIVE ADVISORS LLC (US$37.0M), Saturn V Capital Management LP (US$32.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 XFOR 的基金

查看 XFOR 的全部基金持有人 →

常见问题

How long has Stonepine Capital Management, LLC held XFOR?

Stonepine Capital Management, LLC has disclosed XFOR holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

What is Stonepine Capital Management, LLC's current position in XFOR?

As of Q2 2026, Stonepine Capital Management, LLC holds 224.99K shares of XFOR (X4 PHARMACEUTICALS INC), valued at $1.05M, representing 0.69% of its reported portfolio and ranking #35.

Has Stonepine Capital Management, LLC been buying or selling XFOR?

In the latest 13F filing (Q2 2026), Stonepine Capital Management, LLC reduced its position in XFOR.

Which other funds hold XFOR?

Other major institutional holders of XFOR include Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.